Bio-Rad Laboratories, Inc. (NYSE:BIO) ranks among the best medical stocks to buy according to analysts. On July 31, Bio-Rad Laboratories, Inc. (NYSE:BIO) posted second-quarter earnings that far ...

Shares of Bio-Rad Laboratories were trading higher in the after-hours market following the release of second-quarter financial results that showed the company swinging to a gain for the period. The ...

Ladies and gentlemen, thank you for standing by. My name is Desyree, and I will be your conference operator today. At this time, I would like to welcome everyone to the Bio-Rad First Quarter 2025 ...

Gel Doc XR 是一款快速，简单易用，高分辨率的凝胶成像系统。系统包括了密封暗箱，摄像头，白光和UV 光源，带琥珀型滤片的滤片环，UV 保护档板。它还包括了从图象采集到分析打印一体的Quantity One 1-D 分析软件，以及无安装数量限制的QuantityOne Basic 软件。

北京众力挽生物科技有限公司是一家专业从事ABI型PCR仪、罗氏定量PCR仪、Tecan多功能酶标仪、BD流式细胞仪、超纯水仪等常规、实验室仪器设备的科技公司，我公司产品广泛应用于机械、电子、冶金、化工、航空、天文、轻工、农业等各行业和科研、教育、国防等 ...

We recently published a list of Billionaire Mason Hawkins’ 10 Small-Cap Stocks with Huge Upside Potential. In this article, we are going to take a look at where Bio-Rad Laboratories, Inc. (NYSE:BIO) ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the first quarter of 2025 on ...

Feb 19 (Reuters) - Diagnostics company Bio-Rad (BIO.N), opens new tab has been sued by the California Institute of Technology for allegedly misusing the school's patented technology for analyzing ...

Bio-Rad Laboratories, a Bay Area biotech giant best known for its diagnostic and research products, is laying off 5% of its staff — including more than 100 workers from its headquarters in Hercules.

HERCULES, Calif.--(BUSINESS WIRE)-- Bio-Rad Laboratories, Inc. (BIO.B), a global leader in life science research and clinical diagnostics products, today announced that the company has entered into a ...

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, will report its financial results for the fourth quarter and full year of ...

Aug 1 (Reuters) - Bio-Rad Laboratories (BIO.N), opens new tab cut its annual revenue growth forecast on Thursday, dragged down by weak demand for clinical diagnostics products from biotech clients.